Hypertensive disorders in pregnancy

Hypertensive disorders of pregnancy (HDP) remain among the most significant and intriguing unsolved problems in obstetrics. In India, the prevalence of HDP was 7.8% with pre-eclampsia in 5.4% of the study population. The anaesthetic problems in HDP may be due to the effects on the cardiovascular, respiratory, neurologic, renal, haematologic, hepatic and uteroplacental systems. The basic management objectives should be facilitating the birth of an infant who subsequently thrives and completes restoration of health to the mother, or the termination of pregnancy with the least possible trauma to mother and foetus in severe pre-eclampsia. This comprises obstetric management, adequate foetal surveillance, antihypertensive management, anticonvulsant therapy, safe analgesia for labour and management of anaesthesia for delivery.

[1]  C. Redman.  The management of severe pre-eclampsia. , 1976, Midwife, health visitor & community nurse.

[2]  A. Hollmen,et al.  The Effect of Segmental Epidural Analgesia on Maternal and Foetal Acid‐base Balance, Lactate, Serum Potassium and Creatine Phosphokinase during Labour , 1976, Acta anaesthesiologica Scandinavica.

[3]  S. Walsh,et al.  Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. , 1985, American journal of obstetrics and gynecology.

[4]  A. Saftlas,et al.  Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. , 1990, American journal of obstetrics and gynecology.

[5]  H. Wallenburg,et al.  Central Hemodynamic Observations in Untreated Preeclamptic Patients , 1991, Hypertension.

[6]  G. Dildy,et al.  Spontaneous Rupture of Liver During Pregnancy: Current Therapy , 1991, Obstetrics and gynecology.

[7]  C. Redman,et al.  Management of severe, early pre-eclampsia: is conservative management justified? , 1994, European journal of obstetrics, gynecology, and reproductive biology.

[8]  V. Bhatt-Mehta,et al.  Fetal Exposure to Lisinopril: Neonatal Manifestations and Management , 1993, Pharmacotherapy.

[9]  B. Sibai,et al.  Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.

[10]  M. Quinn.  Automated blood pressure measurement devices: a potential source of morbidity in preeclampsia? , 1994, American journal of obstetrics and gynecology.

[11]  K A Douglas,et al.  Eclampsia in the United Kingdom , 1994, BMJ.

[12]  B. Sibai,et al.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. , 1994, American journal of obstetrics and gynecology.

[13]  The Surfaxin-Lavage for Mas Trial Group.  Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[14]  J. Higgins,et al.  The definition of pre‐eclampsia , 1995, British journal of obstetrics and gynaecology.

[15]  H. Wallenburg,et al.  Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[16]  M. Evans,et al.  PERSISTENCE OF PARTIAL MOLAR PLACENTA AND SEVERE PREECLAMPSIA AFTER SELECTIVE TERMINATION IN A TWIN PREGNANCY , 1996, Obstetrics and gynecology.

[17]  B. Sibai,et al.  Cerebrovascular disorders complicating pregnancy--beyond eclampsia. , 1997, American journal of obstetrics and gynecology.

[18]  P. Bossuyt,et al.  High risk pregnancy monitored antenatally at home. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[19]  M. Kawai,et al.  Transcranial assessment of maternal cerebral blood flow velocity in patients with pre‐eclampsia , 1997, Acta obstetricia et gynecologica Scandinavica.

[20]  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[21]  R. Liston,et al.  Random Protein‐Creatinine Ratio for the Quantitation of Proteinuria in Pregnancy , 1997, Obstetrics and gynecology.

[22]  H. Odendaal,et al.  Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia , 1997, The Lancet.

[23]  G. Bonsel,et al.  Within-subject variability of differences between conventional and automated blood pressure measurements in pregnancy. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[24]  J. Golding,et al.  A randomised trial of low dose aspirin for primiparae in pregnancy , 1998, British journal of obstetrics and gynaecology.

[25]  B. Sibai,et al.  MAGNESIUM SULFATE THERAPY IN PREECLAMPSIA AND ECLAMPSIA , 1998, Obstetrics and gynecology.

[26]  G. Bonsel,et al.  Risk Factors for Preeclampsia in Nulliparous Women in Distinct Ethnic Groups: A Prospective Cohort Study , 1998, Obstetrics and gynecology.

[27]  G. Bonsel,et al.  Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[28]  G. Bonsel,et al.  Low sodium diet and pregnancy‐induced hypertension: a multi‐centre randomised controlled trial , 1998, British journal of obstetrics and gynaecology.

[29]  R. T. Lie,et al.  Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.

[30]  A. Faúndes,et al.  Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. , 1999, American journal of obstetrics and gynecology.

[31]  D. Henderson-smart,et al.  Plasma volume expansion for treatment of pre‐eclampsia , 1999 .

[32]  R. Curry,et al.  Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: a retrospective survey. , 1999, Anesthesiology.

[33]  M. Faas,et al.  Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.

[34]  S. Millard,et al.  Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. , 1999, Obstetrics and gynecology.

[35]  Rick W. Martin,et al.  A 12-Hour Urine Collection Accurately Assesses Proteinuria in the Hospitalized Hypertensive Gravida , 1999, Journal of Perinatology.

[36]  L. Poston,et al.  Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.

[37]  J. N. Martin,et al.  Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome. , 1999, Obstetrical & gynecological survey.

[38]  C. Whitten,et al.  Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. , 1999, Anesthesiology.

[39]  A W Halligan,et al.  Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia. , 1999, American journal of obstetrics and gynecology.

[40]  B. Sibai,et al.  Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. , 2000, American journal of obstetrics and gynecology.

[41]  H. Nisell,et al.  Prediction of maternal and fetal complications in preeclampsia , 2000, Acta obstetricia et gynecologica Scandinavica.

[42]  L. Irgens,et al.  Predicting Preeclampsia in the Second Pregnancy from Low Birth Weight in the First Pregnancy , 2000, Obstetrics and gynecology.

[43]  J. Higgins,et al.  The detection, investigation and management of hypertension in pregnancy: full consensus statement , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

[44]  B. Sibai,et al.  Pregnancy Outcomes in Healthy Nulliparas Who Developed Hypertension , 2000, Obstetrics and gynecology.

[45]  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.

[46]  A. Franx,et al.  High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. , 2000, American journal of obstetrics and gynecology.

[47]  B. Sibai,et al.  HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation. , 2000, American journal of obstetrics and gynecology.

[48]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[49]  D. Grové,et al.  Expectant management of early onset, severe pre‐eclampsia: maternal outcome , 2000, BJOG : an international journal of obstetrics and gynaecology.

[50]  L. Vatten,et al.  Risk factors and clinical manifestations of pre‐eclampsia , 2000, BJOG : an international journal of obstetrics and gynaecology.

[51]  Á. Atallah,et al.  Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2000, The Cochrane database of systematic reviews.

[52]  Z. Calay,et al.  Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre‐eclampsia , 2000, BJOG : an international journal of obstetrics and gynaecology.

[53]  H. Wolf,et al.  MATERNAL OUTCOME FOLLOWING TEMPORIZING MANAGEMENT OF THE (H)ELLP SYNDROME , 2000, Hypertension in pregnancy.

[54]  D. Henderson-smart,et al.  Antiplatelet agents for preventing and treating pre-eclampsia. , 2007, The Cochrane database of systematic reviews.

[55]  H. Wolf,et al.  Long-term follow-up in patients with a history of (H)ELLP syndrome. , 2001, Hypertension in pregnancy.

[56]  R. T. Lie,et al.  Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.

[57]  P. Vigil-De Gracia.  Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[58]  J. Higgins,et al.  Blood-pressure measurement and classification in pregnancy , 2001, The Lancet.

[59]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[60]  C. Kimmel,et al.  Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review. , 2001 .

[61]  F. Goffinet,et al.  Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial , 2001, BJOG : an international journal of obstetrics and gynaecology.

[62]  A. Begum,et al.  A low dose (‘Dhaka’) magnesium sulphate regime for eclampsia , 2001, Acta obstetricia et gynecologica Scandinavica.

[63]  D. Henderson-smart,et al.  Drugs for treatment of very high blood pressure during pregnancy. , 2013, The Cochrane database of systematic reviews.

[64]  M. Brown,et al.  Platelet activation in the hypertensive disorders of pregnancy , 2002, American journal of obstetrics and gynecology.

[65]  Guy E. Thwaites,et al.  The Diagnosis and Management of Tuberculous Meningitis , 2002, Practical Neurology.

[66]  A. Drakeley,et al.  Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. , 2002, American journal of obstetrics and gynecology.

[67]  M. Morgan,et al.  Prospective study of liver dysfunction in pregnancy in Southwest Wales. , 2002, Gut.

[68]  John R Barton,et al.  Late postpartum eclampsia: a preventable disease? , 2002, American journal of obstetrics and gynecology.

[69]  B. Sibai,et al.  Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. , 2002, American journal of obstetrics and gynecology.

[70]  E. Schiffrin,et al.  The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. , 2002, The Canadian journal of cardiology.

[71]  L. Duley,et al.  Interventionist versus expectant care for severe pre-eclampsia before term. , 2002, The Cochrane database of systematic reviews.

[72]  M. Merialdi,et al.  Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials. , 2003, The Journal of nutrition.

[73]  P. Vigil-De Gracia,et al.  Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[74]  P. Bergsjø.  Handbook of Obstetric Medicine , 2003 .

[75]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[76]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.

[77]  A. Stolfi,et al.  Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. , 2003, Obstetrics and gynecology.

[78]  G. Breart,et al.  Aspirin (100 mg) used for prevention of pre‐eclampsia in nulliparous women: the Essai Régional Aspirine Mère–Enfant study (Part 1) , 2003, BJOG : an international journal of obstetrics and gynaecology.

[79]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[80]  R. Hermida,et al.  [Circadian blood pressure variation in normal pregnancy, gestational hypertension, and preeclampsia]. , 2003, Medicina clinica.

[81]  B. Sibai,et al.  Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. , 2003, American journal of obstetrics and gynecology.

[82]  A. Luttun,et al.  Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? , 2003, The Journal of clinical investigation.

[83]  D. Lewis,et al.  Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. , 2003, American journal of obstetrics and gynecology.

[84]  B. Sibai,et al.  Magnesium Sulfate in Women With Mild Preeclampsia: A Randomized Controlled Trial , 2003, Obstetrics and gynecology.

[85]  Fetal Growth and Body Proportion in Preeclampsia , 2003, Obstetrics and gynecology.

[86]  B. Sibai,et al.  Delayed postpartum preeclampsia: an experience of 151 cases. , 2004, American journal of obstetrics and gynecology.

[87]  S. Robboy,et al.  Placental site trophoblastic tumor arising from antecedent molar pregnancy. , 2004, Gynecologic oncology.

[88]  D. Lewis,et al.  Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. , 2004, American journal of obstetrics and gynecology.

[89]  J. Moodley,et al.  Corticosteroids for HELLP syndrome in pregnancy. , 2009, The Cochrane database of systematic reviews.

[90]  K. Khan,et al.  Accuracy of Urinalysis Dipstick Techniques in Predicting Significant Proteinuria in Pregnancy , 2004, Obstetrics and gynecology.

[91]  L. Weinstein.  It has been a great ride: The history of HELLP syndrome. , 2005, American journal of obstetrics and gynecology.

[92]  J. Norman.  The nature of glomerular dysfunction in preeclampsia , 2005 .

[93]  Kirsten Duckitt,et al.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.

[94]  E. Abalos,et al.  Bed rest with or without hospitalisation for hypertension during pregnancy. , 2005, The Cochrane database of systematic reviews.

[95]  L. Magee,et al.  Prevention and treatment of postpartum hypertension. , 2005, The Cochrane database of systematic reviews.

[96]  J. López,et al.  Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[97]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[98]  T. Kazerooni,et al.  Second trimester cardiac output and its predictive value for preeclampsia. , 2006, Saudi medical journal.

[99]  N. Shahbazian,et al.  A comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia. , 2008, Iranian journal of kidney diseases.

[100]  L. McLeod.  How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction? , 2008, Canadian Medical Association Journal.

[101]  A. Franx,et al.  Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial , 2009, The Lancet.

[102]  S. Lowe,et al.  Current management of pre‐eclampsia , 2009, The Medical journal of Australia.

[103]  K. Haram,et al.  The HELLP syndrome: Clinical issues and management. A Review , 2009, BMC pregnancy and childbirth.

[104]  E. Schiffrin,et al.  The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk. , 2009, The Canadian journal of cardiology.

[105]  G. Dekker,et al.  Guidelines for the management of hypertensive disorders of pregnancy 2008 , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[106]  J. Foidart,et al.  [Circulatory and respiratory problems in preeclampsia]. , 2010, Annales francaises d'anesthesie et de reanimation.

[107]  L. Duley,et al.  Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. , 2010, The Cochrane database of systematic reviews.

[108]  R. Levine,et al.  Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease , 2011, Circulation.

[109]  K. Joseph,et al.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[110]  F. Reynolds.  Labour analgesia and the baby: good news is no news. , 2012, International journal of obstetric anesthesia.

[111]  S. Hansson,et al.  Review: Biochemical markers to predict preeclampsia. , 2012, Placenta.

[112]  B. Sibai,et al.  Maternal mortality from preeclampsia/eclampsia. , 2012, Seminars in perinatology.

[113]  A. Dennis.  Management of pre‐eclampsia: issues for anaesthetists , 2012, Anaesthesia.

[114]  G. Hammoud,et al.  Liver diseases in pregnancy: diseases unique to pregnancy. , 2013, World journal of gastroenterology.

[115]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[116]  J. Anthony,et al.  Fluid management in pre-eclampsia , 2013, Obstetric medicine.

[117]  B. Bateman,et al.  Focused review: spinal anesthesia in severe preeclampsia. , 2013, Anesthesia and Analgesia.

[118]  K. Chin,et al.  Regional anesthesia in patients with pregnancy induced hypertension , 2013, Journal of anaesthesiology, clinical pharmacology.

[119]  Jillian T Henderson,et al.  Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force , 2014, Annals of Internal Medicine.

[120]  Lelia Duley,et al.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.

[121]  B. Nagy,et al.  Genetic Aspects of Preeclampsia and the HELLP Syndrome , 2014, Journal of pregnancy.

[122]  L. Magee,et al.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. , 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[123]  R. S. Vela Vásquez,et al.  Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality? , 2015, British journal of anaesthesia.

[124]  A. Faúndes,et al.  Maternal outcomes according to mode of delivery in women with severe preeclampsia: a cohort study , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[125]  A. Shennan,et al.  Faculty Opinions recommendation of Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015 .

[126]  P. Nobis,et al.  Eclampsia in India Through the Decades , 2016, The Journal of Obstetrics and Gynecology of India.

[127]  V. Tsatsaris,et al.  Aspirin for Prevention of Preeclampsia , 2017, Drugs.

[128]  A. Ponzetto,et al.  Hypertensive disorders of pregnancy. , 2018, Journal of hypertension.